rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1999-2-18
|
pubmed:abstractText |
To assess the feasibility safety and side effects of the addition of atropine to dobutamine stress echocardiography for the detection of viable myocardium in patients with left ventricular dysfunction (ejection fraction < or = 35%) prior to coronary revascularization.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0195-668X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1712-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9857925-Adult,
pubmed-meshheading:9857925-Aged,
pubmed-meshheading:9857925-Atropine,
pubmed-meshheading:9857925-Cardiotonic Agents,
pubmed-meshheading:9857925-Dobutamine,
pubmed-meshheading:9857925-Drug Synergism,
pubmed-meshheading:9857925-Electrocardiography,
pubmed-meshheading:9857925-Exercise Test,
pubmed-meshheading:9857925-Feasibility Studies,
pubmed-meshheading:9857925-Female,
pubmed-meshheading:9857925-Heart Rate,
pubmed-meshheading:9857925-Hemodynamics,
pubmed-meshheading:9857925-Humans,
pubmed-meshheading:9857925-Infusions, Intravenous,
pubmed-meshheading:9857925-Male,
pubmed-meshheading:9857925-Middle Aged,
pubmed-meshheading:9857925-Myocardial Ischemia,
pubmed-meshheading:9857925-Parasympatholytics,
pubmed-meshheading:9857925-Ventricular Dysfunction, Left
|
pubmed:year |
1998
|
pubmed:articleTitle |
Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.
|
pubmed:affiliation |
Erasmus University, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|